Literature DB >> 25400732

miR-101 suppresses tumor proliferation and migration, and induces apoptosis by targeting EZH2 in esophageal cancer cells.

Chen Lin1, Fei Huang2, Qiao-Zhi Li1, Ya-Jing Zhang3.   

Abstract

AIM: To investigate the role of miR-101 in the regulation of tumor proliferation, invasion, apoptosis and to its target gene in human ESCC.
METHODS: The expression level of miR-101 in Eca109 cell line was determined by real-time polymerase chain reaction (PCR). After transfected with miR-101 mimics and inhibitor, proliferation, migration and apoptosis in ESCC cell line (Eca109) were detected by MTT, cell wound healing assay and flow cytometry, respectively. The expression of EZH2 in Eca109 cell was examined by immunohistochemical staining.
RESULTS: We found that miR-101 was significantly down-regulated in ESCC cell than in matched normal esophageal epithelium cell. The expression level of miR-101 was inversely correlated to EZH2 protein expression in ESCC cell. In Eca109 cells, over-expression of miR-101 significantly inhibited the migration and invasion of ESCC cells, and promotes cell apoptosis.
CONCLUSIONS: These findings suggest that decreased expression of miR-101 might promote metastasis of human ESCC by inducing accumulation of EZH2 protein.

Entities:  

Keywords:  ESCC; EZH2; MiR-101; invasion; proliferation

Mesh:

Substances:

Year:  2014        PMID: 25400732      PMCID: PMC4230090     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  19 in total

Review 1.  Esophageal cancer.

Authors:  Peter C Enzinger; Robert J Mayer
Journal:  N Engl J Med       Date:  2003-12-04       Impact factor: 91.245

2.  MicroRNA-101 inhibits cell proliferation, invasion, and promotes apoptosis by regulating cyclooxygenase-2 in Hela cervical carcinoma cells.

Authors:  Fei Huang; Chen Lin; Yong-Hua Shi; Gulinar Kuerban
Journal:  Asian Pac J Cancer Prev       Date:  2013

Review 3.  Microenvironmental regulation of cancer metastasis by miRNAs.

Authors:  Yun Zhang; Pengyuan Yang; Xiao-Fan Wang
Journal:  Trends Cell Biol       Date:  2013-10-11       Impact factor: 20.808

4.  MicroRNA-101 suppresses motility of bladder cancer cells by targeting c-Met.

Authors:  Zhenghui Hu; Yiwei Lin; Hong Chen; Yeqing Mao; Jian Wu; Yi Zhu; Xin Xu; Xianglai Xu; Shiqi Li; Xiangyi Zheng; Liping Xie
Journal:  Biochem Biophys Res Commun       Date:  2013-04-22       Impact factor: 3.575

5.  Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma.

Authors:  Chaohui Wu; Minjie Li; Chao Hu; Hongbing Duan
Journal:  Mol Biol Rep       Date:  2014-01-05       Impact factor: 2.316

6.  Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo.

Authors:  Yubin Hao; Xinbin Gu; Yuan Zhao; Stephen Greene; Wei Sha; Duane T Smoot; Joseph Califano; T-C Wu; Xiaowu Pang
Journal:  Cancer Prev Res (Phila)       Date:  2011-03-23

7.  Twist, an independent prognostic marker for predicting distant metastasis and survival rates of esophageal squamous cell carcinoma patients.

Authors:  Fangwei Xie; Kun Li; Xuenong Ouyang
Journal:  Clin Exp Metastasis       Date:  2009-10-09       Impact factor: 5.150

8.  MicroRNA-101 suppresses SOX9-dependent tumorigenicity and promotes favorable prognosis of human hepatocellular carcinoma.

Authors:  Yanqiong Zhang; Xiaodong Guo; Lu Xiong; Xiangying Kong; Ying Xu; Chunfang Liu; Lin Zou; Zhiwei Li; Jingmin Zhao; Na Lin
Journal:  FEBS Lett       Date:  2012-11-21       Impact factor: 4.124

Review 9.  An overview of esophageal squamous cell carcinoma proteomics.

Authors:  Yi-Jun Qi; Wei-Xia Chao; Jen-Fu Chiu
Journal:  J Proteomics       Date:  2012-04-27       Impact factor: 4.044

10.  Detection of HPV DNA in esophageal cancer specimens from different regions and ethnic groups: a descriptive study.

Authors:  Xueqian Wang; Xiuyun Tian; Fangfang Liu; Yiqiang Zhao; Min Sun; Dafang Chen; Changdong Lu; Zhong Wang; Xiaotian Shi; Qingying Zhang; Donghong Zhang; Zhongying Shen; Feng Li; Curtis C Harris; Hong Cai; Yang Ke
Journal:  BMC Cancer       Date:  2010-01-16       Impact factor: 4.430

View more
  18 in total

1.  miR-422a is an independent prognostic factor and functions as a potential tumor suppressor in colorectal cancer.

Authors:  Gui-Xi Zheng; Ai-Lin Qu; Yong-Mei Yang; Xin Zhang; Shou-Cai Zhang; Chuan-Xin Wang
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

2.  MicroRNA-101 polymorphisms and risk of head and neck squamous cell carcinoma in a Chinese population.

Authors:  Limin Miao; Lihua Wang; Hua Yuan; Dong Hang; Longbiao Zhu; Jiangbo Du; Xun Zhu; Bing Li; Ruixia Wang; Hongxia Ma; Ning Chen
Journal:  Tumour Biol       Date:  2015-10-22

3.  MicroRNA-101 regulates the viability and invasion of cervical cancer cells.

Authors:  Chen Lin; Fei Huang; Guqun Shen; Adilijiang Yiming
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

4.  Oxidative stress, epigenetics, and cancer stem cells in arsenic carcinogenesis and prevention.

Authors:  Lingzhi Li; Fei Chen
Journal:  Curr Pharmacol Rep       Date:  2016-01-23

5.  Exosomal transfer of miR-429 confers chemoresistance in epithelial ovarian cancer.

Authors:  Taoqiong Li; Li Lin; Qin Liu; Wujiang Gao; Lu Chen; Chunli Sha; Qi Chen; Wenlin Xu; Yuefeng Li; Xiaolan Zhu
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

Review 6.  Key nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancer.

Authors:  Yan Sun; Fei Guo; Marina Bagnoli; Feng-Xia Xue; Bao-Cun Sun; Ilya Shmulevich; Delia Mezzanzanica; Ke-Xin Chen; Anil K Sood; Da Yang; Wei Zhang
Journal:  Chin J Cancer       Date:  2015-01

7.  Histone demethylase KDM2B upregulates histone methyltransferase EZH2 expression and contributes to the progression of ovarian cancer in vitro and in vivo.

Authors:  Yan Kuang; Fangfang Lu; Jianfeng Guo; Hong Xu; Qi Wang; Chaohuan Xu; Longjia Zeng; Suyi Yi
Journal:  Onco Targets Ther       Date:  2017-06-26       Impact factor: 4.147

8.  miR-101 reverses hypomethylation of the PRDM16 promoter to disrupt mitochondrial function in astrocytoma cells.

Authors:  Qianqian Lei; Xiaoping Liu; Haijuan Fu; Yingnan Sun; Liping Wang; Gang Xu; Wei Wang; Zhibin Yu; Changhong Liu; Peiyao Li; Jianbo Feng; Guiyuan Li; Minghua Wu
Journal:  Oncotarget       Date:  2016-01-26

9.  Cyclooxygenase-2, a Potential Therapeutic Target, Is Regulated by miR-101 in Esophageal Squamous Cell Carcinoma.

Authors:  Ying Shao; Peng Li; Sheng-tao Zhu; Ji-ping Yue; Xiao-jun Ji; Zhen He; Dan Ma; Li Wang; Yong-jun Wang; Ye Zong; Yong-dong Wu; Shu-tian Zhang
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

10.  MicroRNA-101 targets von Hippel-Lindau tumor suppressor (VHL) to induce HIF1α mediated apoptosis and cell cycle arrest in normoxia condition.

Authors:  Ning Liu; Wu-Yan Xia; Shan-Shan Liu; Hai-Yan Chen; Lei Sun; Meng-Yao Liu; Lin-Feng Li; Hong-Min Lu; Yu-Jie Fu; Pei Wang; Hailong Wu; Jian-Xin Gao
Journal:  Sci Rep       Date:  2016-02-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.